U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 ('793 Patent)
Calliditas Therapeutics announces full FDA approval of TARPEYO®, the only FDA-approved treatment for IgA nephropathy to significantly reduce the loss of kidney function
Dare Bioscience Announces Positive Topline Pharmacokinetic and Exploratory Efficacy Results from the DARE-PDM1 Phase 1 Clinical Study
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished
AtriCure to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Hypertension Control Program Aims to Tackle Major Driver of Health Disparities for Black Americans
Chiesi Global Rare Diseases Receives FDA Approval for FILSUVEZ® (birch triterpenes) topical gel for the Treatment of Epidermolysis Bullosa
Introducing Inhibitor Therapeutics, Inc. New Scientific Advisory Board
Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over Capecitabine
NRx Pharmaceuticals Announces Signing of a Data and Technical Information Agreement with Columbia University Accessing Key Data Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Depression
 5   6   7   8   9     10    11   12   13   14   15 
 <<   <   >   >>